From Our Thought Leaders

Vector BioMed COO Mike Kadan on Reinventing Viral Vector Manufacturing for a Decentralized Gene Therapy Future

In this exclusive interview with BioPharma BoardRoom, Mike Kadan, Chief Operating Officer of Vector BioMed, shares how the company is reimagining viral vector manufacturing through a purpose-built, modular platform designed to deliver high-quality le... Read more

25 April, 2025 | Friday | Interview
Marc N. Casper Steers Thermo Fisher to Strong Q1 Results with $10.36 Billion Revenue and 15% EPS Growth, Defying Economic Headwinds

  First quarter revenue was $10.36 billion. First quarter GAAP diluted earnings per share (EPS) grew 15% to $3.98. First quarter adjusted EPS grew 1% to $5.15. Delivered very strong financial performance in the quarter, demonstrating t... Read more

24 April, 2025 | Thursday | Company results
John Rim Drives Samsung Biologics to KRW 1.3 Trillion Q1 Revenue as Plant 5 and ADC Facility Fuel Global CDMO Expansion

- Recorded Q1’25 consolidated revenue of KRW 1.3 trillion - Recorded Q1’25 consolidated operating profit of KRW 486.7 billion - Company expected to maintain steady growth momentum in 2025 driven by enhanced operational efficiency and ... Read more

24 April, 2025 | Thursday | Company results
Sanofi CEO Paul Hudson Confident in 2025 Growth Trajectory as Q1 Sales Climb 9.7% and Pipeline Delivers Six Approvals

CEO Paul Hudson: Confidence in Full-Year Outlook Paul Hudson, Chief Executive Officer: “We had a strong start in 2025 with sales growth of 9.7%, benefiting from investments in innovation and a favorable base of comparison. Our focus on pipel... Read more

24 April, 2025 | Thursday | Company results

Bio Finance

President Trump Signs Executive Order to Lower Drug Prices, Focuses on Medicare Negotiations and Pharmacy Benefit Manager Reforms

President Trump issued an Executive Order titled Lowering Drug Prices by Once Again Putting Americans First on Tuesday, April 15. The Executive Order called for the Administration and Congress to continue efforts from the first Trump Admini... Read more

18 April, 2025 | Friday | News
Paratek Pharmaceuticals to Acquire Optinose for Up to $330 Million, Expanding Portfolio with XHANCE®

Paratek Pharmaceuticals and Optinose, Inc. announced they have entered into a definitive merger agreement under which Paratek will acquire Optinose, including its approved product XHANCE® (fluticasone propionate). The transaction value is up... Read more

21 March, 2025 | Friday | News

Contract Services

Meribel Pharma Solutions Launches as Mid-Size European CDMO with 13 Sites Across France, Spain, and Sweden

A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network across Europe, led by a team of industry experts on a mission to deliver the highest quality so... Read more

15 April, 2025 | Tuesday | News
Lonza Launches New Operating Model to Power ‘One Lonza’ Vision and Streamline CDMO Business

Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy Previous divisional structure is now replaced with three newly formed CDMO Business Platforms: Integrated Biologics, Advanced... Read more

02 April, 2025 | Wednesday | News

BioPharma Video

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close